Your browser doesn't support javascript.
loading
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer.
Cornely, Oliver A; Mullane, Kathleen M; Birch, Thomas; Hazan-Steinberg, Sabine; Nathan, Richard; Bouza, Emilio; Calfee, David P; Ellison, Misoo Chung; Wong, Michael T; Dorr, Mary Beth.
Affiliation
  • Cornely OA; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.
  • Mullane KM; Section of Infectious Diseases, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Birch T; Holy Name Medical Center, Teaneck, New Jersey, USA.
  • Hazan-Steinberg S; Ventura Clinical Trials, Ventura, California, USA.
  • Nathan R; Idaho Falls Infectious Diseases, Idaho Falls, Idaho, USA.
  • Bouza E; Department of Medicine, Universidad Complutense, Department of Microbiology and Infectious Diseases, Hospital Gregorio Maranon, CIBERES, Madrid, Spain.
  • Calfee DP; Weill Cornell Medicine, New York, New York, USA.
  • Ellison MC; Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Wong MT; Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Dorr MB; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Open Forum Infect Dis ; 7(2): ofaa038, 2020 Feb.
Article in En | MEDLINE | ID: mdl-32099847

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Open Forum Infect Dis Year: 2020 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Open Forum Infect Dis Year: 2020 Type: Article Affiliation country: Germany